Published in Virology on April 01, 1995
Memory inflation during chronic viral infection is maintained by continuous production of short-lived, functional T cells. Immunity (2008) 3.33
Immunobiology of human cytomegalovirus: from bench to bedside. Clin Microbiol Rev (2009) 2.75
Reactivation of the previously silenced cytomegalovirus major immediate-early promoter in the mouse liver: involvement of NFkappaB. J Virol (1998) 2.23
Lipopolysaccharide, tumor necrosis factor alpha, or interleukin-1beta triggers reactivation of latent cytomegalovirus in immunocompetent mice. J Virol (2006) 1.37
Allogeneic transplantation induces expression of cytomegalovirus immediate-early genes in vivo: a model for reactivation from latency. J Virol (2001) 1.35
Activation of herpesvirus gene expression by the human cytomegalovirus protein pp71. J Virol (1999) 1.29
Role of the proximal enhancer of the major immediate-early promoter in human cytomegalovirus replication. J Virol (2004) 1.22
In vivo replication of recombinant murine cytomegalovirus driven by the paralogous major immediate-early promoter-enhancer of human cytomegalovirus. J Virol (1999) 1.22
Neutrality of the canonical NF-kappaB-dependent pathway for human and murine cytomegalovirus transcription and replication in vitro. J Virol (2004) 1.21
Cytomegalovirus-induced immunopathology and its clinical consequences. Herpesviridae (2011) 1.19
Role for tumor necrosis factor alpha in murine cytomegalovirus transcriptional reactivation in latently infected lungs. J Virol (2005) 1.18
The cytomegaloviral protein pUL138 acts as potentiator of tumor necrosis factor (TNF) receptor 1 surface density to enhance ULb'-encoded modulation of TNF-α signaling. J Virol (2011) 1.17
Random, asynchronous, and asymmetric transcriptional activity of enhancer-flanking major immediate-early genes ie1/3 and ie2 during murine cytomegalovirus latency in the lungs. J Virol (2001) 1.16
Anti-human immunodeficiency virus type 1 microbicide cellulose acetate 1,2-benzenedicarboxylate in a human in vitro model of vaginal inflammation. Antimicrob Agents Chemother (2005) 1.13
Real-time monitoring of nuclear factor kappaB activity in cultured cells and in animal models. Mol Imaging (2009) 1.13
Human cytomegalovirus inhibits differentiation of monocytes into dendritic cells with the consequence of depressed immunological functions. J Virol (2003) 1.01
Cytomegalovirus reactivation in critically ill immunocompetent hosts: a decade of progress and remaining challenges. Antiviral Res (2011) 1.00
Human cytomegalovirus blocks tumor necrosis factor alpha- and interleukin-1beta-mediated NF-kappaB signaling. J Virol (2006) 1.00
Disease-inducible transgene expression from a recombinant adeno-associated virus vector in a rat arthritis model. J Virol (1999) 0.96
Regulation of the transcription and replication cycle of human cytomegalovirus is insensitive to genetic elimination of the cognate NF-kappaB binding sites in the enhancer. J Virol (2006) 0.96
The human cytomegalovirus virion possesses an activated casein kinase II that allows for the rapid phosphorylation of the inhibitor of NF-kappaB, IkappaBalpha. J Virol (2007) 0.94
Sepsis and cytomegalovirus: foes or conspirators? Med Microbiol Immunol (2015) 0.94
Human cytomegalovirus inhibits cytokine-induced macrophage differentiation. J Virol (2004) 0.90
Wingless homolog Wnt11 suppresses bacterial invasion and inflammation in intestinal epithelial cells. Am J Physiol Gastrointest Liver Physiol (2011) 0.89
Inflammaging decreases adaptive and innate immune responses in mice and humans. Biogerontology (2015) 0.88
Cytomegalovirus (CMV) seropositivity decreases B cell responses to the influenza vaccine. Vaccine (2015) 0.87
Biphasic recruitment of transcriptional repressors to the murine cytomegalovirus major immediate-early promoter during the course of infection in vivo. J Virol (2010) 0.87
Murine cytomegalovirus immediate-early promoter directs astrocyte-specific expression in transgenic mice. Am J Pathol (1999) 0.86
Plasmid injection and application of electric pulses alter endogenous mRNA and protein expression in B16.F10 mouse melanomas. Cancer Gene Ther (2010) 0.85
Impact of aging on viral infections. Microbes Infect (2010) 0.84
Dendritic cell biology in human cytomegalovirus infection and the clinical consequences for host immunity and pathology. Virulence (2012) 0.84
JFC1 is transcriptionally activated by nuclear factor-kappaB and up-regulated by tumour necrosis factor alpha in prostate carcinoma cells. Biochem J (2002) 0.80
Aging, cytomegalovirus (CMV) and influenza vaccine responses. Hum Vaccin Immunother (2016) 0.79
Incidence, risk factors, and outcomes of delayed-onset cytomegalovirus disease in a large, retrospective cohort of heart transplant recipients. Transplant Proc (2014) 0.79
Heat shock enhances CMV-IE promoter-driven metabotropic glutamate receptor expression and toxicity in transfected cells. Neuropharmacology (2011) 0.78
Thrombin induces Sp1-mediated antiviral effects in cytomegalovirus-infected human retinal pigment epithelial cells. Med Microbiol Immunol (2003) 0.78
TNF-alpha signaling is not required for in vivo transcriptional reactivation of latent murine cytomegalovirus. Transplantation (2009) 0.77
Is immunosenescence influenced by our lifetime "dose" of exercise? Biogerontology (2016) 0.76
The human cytomegalovirus lytic cycle is induced by 1,25-dihydroxyvitamin D3 in peripheral blood monocytes and in the THP-1 monocytic cell line. Virology (2015) 0.76
Cytomegalovirus as a cause of hypertensive anterior uveitis in immunocompetent patients. J Ophthalmic Inflamm Infect (2016) 0.75
Activation of Langerhans-Type Dendritic Cells Alters Human Cytomegalovirus Infection and Reactivation in a Stimulus-Dependent Manner. Front Microbiol (2016) 0.75
Transplant-induced reactivation of murine cytomegalovirus immediate early gene expression is associated with recruitment of NF-κB and AP-1 to the major immediate early promoter. J Gen Virol (2016) 0.75
Impact of Aging and Cytomegalovirus on Immunological Response to Influenza Vaccination and Infection. Front Immunol (2017) 0.75
MAPKAP kinase 2 is essential for LPS-induced TNF-alpha biosynthesis. Nat Cell Biol (1999) 5.75
Monocyte deactivation in septic patients: restoration by IFN-gamma treatment. Nat Med (1997) 5.19
Biology of DNA restriction. Microbiol Rev (1993) 5.10
Interleukin-10 therapy--review of a new approach. Pharmacol Rev (2003) 3.51
Coordinate regulation of multiple histone mRNAs during the cell cycle in HeLa cells. Nucleic Acids Res (1983) 3.35
A novel method for efficient amplification of whole hepatitis B virus genomes permits rapid functional analysis and reveals deletion mutants in immunosuppressed patients. J Virol (1995) 3.35
Prevalence of incidental Bochdalek's hernia in a large adult population. AJR Am J Roentgenol (2001) 3.24
Bacteriophage survival: multiple mechanisms for avoiding the deoxyribonucleic acid restriction systems of their hosts. Microbiol Rev (1983) 3.13
Endotoxin and immune activation in chronic heart failure: a prospective cohort study. Lancet (1999) 3.01
Altered peptide ligands can control CD4 T lymphocyte differentiation in vivo. J Exp Med (1995) 2.80
Country profile: Germany. Lancet (1996) 2.77
Folate and chemoprevention of colorectal cancer: Is 5-methyl-tetrahydrofolate an active antiproliferative agent in folate-treated colon-cancer cells? Nutrition (2001) 2.75
The nuclear domain 10 (ND10) is disrupted by the human cytomegalovirus gene product IE1. Exp Cell Res (1996) 2.69
UL69 of human cytomegalovirus, an open reading frame with homology to ICP27 of herpes simplex virus, encodes a transactivator of gene expression. J Virol (1994) 2.69
T-cell epitope mapping by flow cytometry. Nat Med (1998) 2.56
Target structures of the CD8(+)-T-cell response to human cytomegalovirus: the 72-kilodalton major immediate-early protein revisited. J Virol (1999) 2.55
Sequence and organization of genes encoding the human 27 kDa heat shock protein. Nucleic Acids Res (1986) 2.34
Effect of filgrastim treatment on inflammatory cytokines and lymphocyte functions. Clin Pharmacol Ther (1999) 2.33
Personal exercise habits and counseling practices of primary care physicians: a national survey. Clin J Sport Med (2000) 2.31
Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med (1998) 2.30
Analysis of CD8 T cell reactivity to cytomegalovirus using protein-spanning pools of overlapping pentadecapeptides. Eur J Immunol (2000) 2.29
Upregulation of heme oxygenase-1 protects genetically fat Zucker rat livers from ischemia/reperfusion injury. J Clin Invest (1999) 2.29
Analysis of histone gene expression during the cell cycle in HeLa cells by using cloned human histone genes. Proc Natl Acad Sci U S A (1982) 2.28
Plasma cytokine parameters and mortality in patients with chronic heart failure. Circulation (2000) 2.18
Laryngeal transplantation and 40-month follow-up. N Engl J Med (2001) 2.12
Organization of human histone genes. Proc Natl Acad Sci U S A (1982) 2.10
Type III restriction enzymes need two inversely oriented recognition sites for DNA cleavage. Nature (1992) 2.04
Transmission of hepatitis C virus to children and husbands by women infected with contaminated anti-D immunoglobulin. Lancet (1995) 2.03
Mechanism of endotoxin desensitization: involvement of interleukin 10 and transforming growth factor beta. J Exp Med (1995) 2.03
Protein-DNA interactions in vivo upstream of a cell cycle-regulated human H4 histone gene. Science (1987) 1.97
Covalent modification of the transactivator protein IE2-p86 of human cytomegalovirus by conjugation to the ubiquitin-homologous proteins SUMO-1 and hSMT3b. J Virol (2000) 1.91
Inhibition of DNA replication coordinately reduces cellular levels of core and H1 histone mRNAs: requirement for protein synthesis. Biochemistry (1984) 1.88
Reassessment of histone gene expression during cell cycle in human cells by using homologous H4 histone cDNA. Proc Natl Acad Sci U S A (1979) 1.87
Functional interaction between the human cytomegalovirus 86-kilodalton IE2 protein and the cellular transcription factor CREB. J Virol (1995) 1.85
Analysis of proteins encoded by IE regions 1 and 2 of human cytomegalovirus using monoclonal antibodies generated against recombinant antigens. Virology (1993) 1.83
Up-regulation of monocytic IL-10 by tumor necrosis factor-alpha and cAMP elevating drugs. Int Immunol (1995) 1.81
Changing motor synergies in chronic stroke. J Neurophysiol (2007) 1.77
Type III restriction endonucleases translocate DNA in a reaction driven by recognition site-specific ATP hydrolysis. EMBO J (1995) 1.77
Bacteriophage T3 and bacteriophage T7 virus-host cell interactions. Microbiol Rev (1981) 1.76
Stroke-induced immunodepression and post-stroke infections: lessons from the preventive antibacterial therapy in stroke trial. Neuroscience (2008) 1.75
A specific subform of the human cytomegalovirus transactivator protein pUL69 is contained within the tegument of virus particles. J Virol (1996) 1.74
Identification of binding sites for the 86-kilodalton IE2 protein of human cytomegalovirus within an IE2-responsive viral early promoter. J Virol (1994) 1.73
Regulation of cell cycle stage-specific transcription of histone genes from chromatin by non-histone chromosomal proteins. Nature (1975) 1.68
Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer. J Exp Med (1991) 1.66
Systemic inflammation in patients with heart failure. Eur Heart J (1998) 1.64
Late-acute renal allograft rejection and symptomless cytomegalovirus infection. Lancet (1995) 1.63
Iron overload following bone marrow transplantation in children: MR findings. Pediatr Radiol (1997) 1.63
Elevated soluble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol (1997) 1.63
Cyclic adenosine monophosphate-responsive elements are involved in the transcriptional activation of the human IL-10 gene in monocytic cells. Eur J Immunol (1999) 1.63
Distribution of human CMV-specific memory T cells among the CD8pos. subsets defined by CD57, CD27, and CD45 isoforms. Eur J Immunol (1999) 1.62
A neuroanatomical hypothesis for panic disorder. Am J Psychiatry (1989) 1.62
Poverty, health services, and health status in rural America. Milbank Q (1988) 1.61
Contrast sensitivity and coherent motion detection measured at photopic luminance levels in dyslexics and controls. Vision Res (1995) 1.60
Renal cell carcinoma metastatic to the pancreas: a single-institution series and review of the literature. Urology (2000) 1.59
Influence of physical exercise on polyamine synthesis in the rat skeletal muscle. Eur J Clin Invest (2000) 1.59
A major human histone gene cluster on the long arm of chromosome 1. Science (1984) 1.59
Impaired antigen presentation by human monocytes during endotoxin tolerance. Blood (2000) 1.58
Changes in DNA base sequence induced by gamma-ray mutagenesis of lambda phage and prophage. Genetics (1988) 1.56
A novel transferable nuclear export signal mediates CRM1-independent nucleocytoplasmic shuttling of the human cytomegalovirus transactivator protein pUL69. EMBO J (2001) 1.55
Decreased oxidative stress in patients with idiopathic dilated cardiomyopathy one year after immunoglobulin adsorption. J Am Coll Cardiol (2001) 1.55
Cytomegalovirus reactivation and tumour necrosis factor. Lancet (1994) 1.55
Recombination in Tula hantavirus evolution: analysis of genetic lineages from Slovakia. J Virol (1999) 1.54
Effect of granulocyte colony-stimulating factor treatment on ex vivo blood cytokine response in human volunteers. Blood (1995) 1.52
Structure and in vitro transcription of a human H4 histone gene. Nucleic Acids Res (1983) 1.51
The UL84 protein of human cytomegalovirus acts as a transdominant inhibitor of immediate-early-mediated transactivation that is able to prevent viral replication. J Virol (1997) 1.49
Effect of monocular occlusion on visuomotor perception and reading in dyslexic children. Lancet (1985) 1.48
Involvement of the 5'-leader sequence in coupling the stability of a human H3 histone mRNA with DNA replication. Proc Natl Acad Sci U S A (1986) 1.47
Primary care physicians' views on access and health care reform: the situation in North Carolina. J Fam Pract (1993) 1.46
Postoperative course of S-100B protein and neuron-specific enolase in patients after implantation of continuous and pulsatile flow LVADs. J Heart Lung Transplant (2001) 1.45
Immunomodulatory therapies in sepsis. Intensive Care Med (2000) 1.45
Dobrava hantavirus causes hemorrhagic fever with renal syndrome in central Europe and is carried by two different Apodemus mice species. J Med Virol (2001) 1.42
[Adult-onset Still's disease. Differential diagnosis in recurrent pharyngitis, fever of unknown original and excessive hyperferritinemia]. Dtsch Med Wochenschr (1999) 1.42
Planning, delivery, and quality assurance of intensity-modulated radiotherapy using dynamic multileaf collimator: a strategy for large-scale implementation for the treatment of carcinoma of the prostate. Int J Radiat Oncol Biol Phys (1997) 1.42
Functional interaction between pleiotropic transactivator pUL69 of human cytomegalovirus and the human homolog of yeast chromatin regulatory protein SPT6. J Virol (2000) 1.41
Rationale for the luminal provision of butyrate in intestinal diseases. Eur J Nutr (2000) 1.40
Extended family studies for the identification of allogeneic stem cell transplant donors in Jewish and Arabic patients in Israel. Pediatr Transplant (2005) 1.40
The tissue-specific nuclear matrix protein, NMP-2, is a member of the AML/CBF/PEBP2/runt domain transcription factor family: interactions with the osteocalcin gene promoter. Biochemistry (1995) 1.40
IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach. J Clin Invest (1998) 1.40
Verrucosis of hands and feet in a patient with combined immune deficiency. J Am Acad Dermatol (1997) 1.39
The role of a repetitive palindromic sequence element in the human cytomegalovirus major immediate early enhancer. J Gen Virol (1989) 1.39
[Pathogenesis and treatment of pruritus in patients with cholestasis]. Z Gastroenterol (2003) 1.38
Adherence among children and adolescents with insulin-dependent diabetes mellitus over a four-year longitudinal follow-up: II. Immediate and long-term linkages with the family milieu. J Pediatr Psychol (1990) 1.38
Modulation of epidermal growth factor-induced cell proliferation by an omega-3 fatty-acid-containing lipid emulsion on human pancreatic cancer cell line Mia Paca-2. Nutrition (2001) 1.38
Recombinant green fluorescent protein-expressing human cytomegalovirus as a tool for screening antiviral agents. Antimicrob Agents Chemother (2000) 1.37
Hyperventilation induces release of cytokines from perfused mouse lung. Am J Respir Crit Care Med (1998) 1.36
Studies on the ecology of Lyme disease in a deer forest in County Galway, Ireland. J Med Entomol (1992) 1.34
An inducible promoter mediates abundant expression from the immediate-early 2 gene region of human cytomegalovirus at late times after infection. J Virol (1991) 1.33
Tumour necrosis factor alpha stimulates the activity of the human cytomegalovirus major immediate early enhancer/promoter in immature monocytic cells. J Gen Virol (1993) 1.33
A novel link between stress and human cytomegalovirus (HCMV) infection: sympathetic hyperactivity stimulates HCMV activation. Virology (2000) 1.32
DNA cleavage by type III restriction-modification enzyme EcoP15I is independent of spacer distance between two head to head oriented recognition sites. J Mol Biol (2001) 1.32